Skip to Content

Viemed leverages tailwinds

Viemed leverages tailwinds

Casey HoytLAFAYETTE, La. – Viemed reported core net revenues of $43.3 million for the second quarter 2023, an increase of 31% compared to one year ago and a new company record. 

Net income for the quarter totaled $2.3 million, including approximately $2.5 million of revenues related to its acquisition of Home Medical Products, which it completed June 1. Adjusted EBITDA totaled $9.8 million. 

“We find ourselves in an exceptional position, leveraging the prevailing tailwinds in the operating environment to extend our reach and impact on more patients than ever before,” said Casey Hoyt, CEO. "The foundation of our success lies in our robust and resilient business model, which has consistently demonstrated its strength in meeting challenges head-on and driving sustainable growth. We are now taking our growth to new heights by executing on strategic and accretive acquisitions that complement our existing capabilities. These acquisitions serve as powerful catalysts, accelerating the expansion of our comprehensive respiratory offerings." 

Viemed expects to generate net revenues of approximately $49 million to $50 million during the third quarter of 2023.


To comment on this post, please log in to your account or set up an account now.